Transcripts Revolution Medicines, Inc.

Equities

RVMD

US76155X1000

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
40.34 ^USD	+0.47%		+5.24%	+40.66%

Jun. 05	Revolution Medicines Insider Sold Shares Worth $299,942, According to a Recent SEC Filing	MT
May. 09	Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating	MT

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Revolution Medicines, Inc., Q1 2024 Earnings Call, May 08, 2024	May. 08
Transcript : Revolution Medicines, Inc., Q4 2023 Earnings Call, Feb 26, 2024	Feb. 26
Transcript : Revolution Medicines, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 11:15 AM	Jan. 09
Transcript : Revolution Medicines, Inc., Q3 2023 Earnings Call, Nov 06, 2023	Nov. 06
Transcript : Revolution Medicines, Inc. - Special Call	23-10-22
Transcript : Revolution Medicines, Inc., Q2 2023 Earnings Call, Aug 08, 2023	23-08-08
Transcript : EQRx, Inc., Revolution Medicines, Inc. - M&A Call	23-08-01
Transcript : Revolution Medicines, Inc. Presents at Barclays Virtual Fireside Chat Series, Jun-15-2023 12:00 PM	23-06-15
Transcript : Revolution Medicines, Inc. Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-14-2023 08:40 AM	23-06-14
Transcript : Revolution Medicines, Inc., Q1 2023 Earnings Call, May 08, 2023	23-05-08
Transcript : Revolution Medicines, Inc., Q4 2022 Earnings Call, Feb 27, 2023	23-02-27
Transcript : Revolution Medicines, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 11:15 AM	23-01-10
Transcript : Revolution Medicines, Inc., Q3 2022 Earnings Call, Nov 07, 2022	22-11-07
Revolution Medicines, Inc. Provides Earnings Guidance for the Full Year 2022	22-11-07	CI
Transcript : Revolution Medicines, Inc., Q2 2022 Earnings Call, Aug 09, 2022	22-08-09
Revolution Medicines, Inc. Provides Earnings Guidance for the Year 2022	22-08-09	CI
Transcript : Revolution Medicines, Inc. Presents at Goldman Sachs 43rd Annual Global Healthcare Conference, Jun-15-2022 01:20 PM	22-06-15
Transcript : Revolution Medicines, Inc., Q1 2022 Earnings Call, May 09, 2022	22-05-09
Revolution Medicines, Inc. Reiterates Earnings Guidance for the Full Year 2022	22-05-09	CI
Transcript : Revolution Medicines, Inc., Q4 2021 Earnings Call, Feb 28, 2022	22-02-28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Transcripts Revolution Medicines, Inc.

Equities

RVMD

US76155X1000

Transcripts

Filters